Physician profile
Connor Oates
NPI 1689178428
$60,140.36
in general payments reported to CMS, 2019-2025
16 companies · $33K in 2025
The $33K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $1,037 · 2024: $26K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $48K · Food and Beverage: $11K · Travel and Lodging: $1,207 · Education: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $47,500.00 |
| Food and Beverage | $10,671.36 |
| Travel and Lodging | $1,207.03 |
| Education | $615.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $35,146.11 | 2022-2025 | Assurity, Tacticath, Aveir |
| Boston Scientific Corporation | $19,819.08 | 2024-2025 | Farapulse, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $2,514.35 | 2024-2025 | Cobalt Dr Mri Surescan, Micra, Affera Mapping System |
| Biosense Webster, INC. | $1,256.31 | 2024-2025 | Carto 3 |
| Cardiva Medical, INC. | $654.20 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $203.62 | 2023-2024 | Lifevest |
| Biotronik INC. | $94.19 | 2025 | |
| Abiomed | $83.30 | 2024-2025 | Impella |
| Angiodynamics, INC. | $78.34 | 2025 | Alphavac |
| Cordis US Corp. | $77.99 | 2024 | Mynx Control, Mynx Venous Vcd |
| Philips North America LLC | $71.65 | 2024 | (Ck4) Mcot |
| Irhythm Technologies, INC. | $41.93 | 2024 | Zio Monitor, Zio Xt Patch |
| Kestra Medical Technology Services, INC. | $37.33 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $26.37 | 2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $21.09 | 2024 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $14.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Oates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.